ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability ...Middle East

The study has achieved its primary objectives, confirming the safety and tolerability profile of TLX591 administered in two doses, two weeks apart in combination with standard of care (SoC) Preliminary activity demonstrates meaningful PSA[1] reduction; monitoring of patients is ongoing,...

Hence then, the article about prostact select study of tlx591 interim readout positive results confirm safety and tolerability was published today ( Thursday 19/10/2023 - 01:33 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability )

Also on site :

• Olympic Gymnastics Legend, Who Scored the World’s First Perfect 10, Relives Her Greatest Performance 50 Years Later
• ABBA’s Björn Ulvaeus Talks AI Training at United Nations Summit: Artists ‘Deserve a Place at the Table’
• Mississippi’s history of racism is a talking point as investigation unfolds in the mysterious death of Nolan Xavier Wells